科学家创造了新的vancomycin版本,针对细菌细胞壁,对抗抗生素抗药性。 Scientists create new vancomycin version that targets bacterial cell walls, combating antibiotic resistance.

加州大学欧文分校的科学家们开发了一种新版抗生素万古霉素，针对细菌表面分子的两个部分。 Scientists from the University of California, Irvine have developed a new version of the antibiotic vancomycin that targets two parts of bacterial surface molecules. 这一创新可以制止不断研制抗抗生素抗菌细菌新药物的需要,从而有可能结束正在进行的抗生素细菌军备竞赛。 This innovation could stop the need for constantly developing new drugs against antibiotic-resistant bacteria, potentially ending the ongoing antibiotic-bacteria arms race. 这种新药防止细菌建立防护性细胞墙壁,使其成为对付抗生素抗药性的一个重要步骤。 The new drug prevents bacteria from building protective cell walls, making it a significant step in tackling antibiotic resistance.